Bayer publishes crop protection safety studies

Bayer, through its transparency initiative, is now offering full, in-depth, safety-related study reports providing they are not used for commercial purpose. Bayer’s transparency platform, cropscience-transparency.bayer.com demonstrates how transparency around crop protection safety studies can be improved, while at the same time safeguarding confidential business information.

“Bayer’s initiative leads the way regarding the transparency of crop protection studies. We welcome the European Commission’s plan to make industry studies more transparent while respecting the need to protect legitimate confidential business information,” says Dr. Adrian Percy, global head of Research and Development for the Crop Science Division. “It is critical to ensure that safety data is made available strictly for non-commercial use in order to protect and continue promoting innovation.”

First announced in 2016, Bayer’s transparency initiative aims to break down barriers to build public trust and foster a fair, science-based dialogue around crop protection products. The platform was launched in 2017. Until now, mostly study summaries were available in addition to safety-related study reports on the active substance imidacloprid.

For more information:
cropscience-transparency.bayer.com